MCB Professor of Neurobiology, Mu-ming Poo has recently published a paper in Science addressing a fundamental question of neurodevelopment about how neurons become polarized -- i.e. how growing neurites in a young neuron decide whether to become an axon or a dendrite. His group showed that reciprocal interactions between intracellular signaling cascades underlie this event.
Below are articles from various sources about members of MCB and their research.
Associate Professor of Cell and Developmental Biology David Bilder will receive the 2010 Harland Winfield Mossman Award in Developmental Biology and present an award lecture on ‰ÛÏFunction Follows Form: Linking Epithelial Polarity, Growth Control, and Morphogenesis in Drosophila‰Û during the Young Investigator Symposium at the Annual Meeting of the American Association of Anatomists (AAA)/Experimental Biology (EB) 2010.
The Cell & Developmental Biology Division is hosting a one-day Symposium on Non-coding RNA on March 23, 2010. Information about the schedule, speakers and free registration are available by following the link below.
In a report in this week's early online edition of the journal Proceedings of the National Academy of Sciences, University of California, Berkeley, researchers show that the H1N1, or swine flu, virus adopted a new mutation in one of its genes distinct from the mutations found in previous flu viruses, including those responsible for the Spanish influenza pandemic of 1918, the "Asian" flu pandemic in 1957 and the "Hong Kong" pandemic of 1968.Read more...
Erol Kepkep began working at the campus‰Ûªs Department of Instruction in Biology in 1987, when he was an undergraduate completing a double major in molecular biology and genetics. In 1989, he moved into the Molecular and Cell Biology Department, where he and his staff are responsible for two Biology 1A lab classrooms. Among the challenges of the job: tracking the lab‰Ûªs snakes and crocodiles when they go missing, juggling enrollment for 600-plus students each semester, and helping protozoans and cyanobacteria flourish.
President Barack Obama's stimulus package is already stimulating innovation and jobs at the University of California, Berkeley, with more than 130 projects underway. The work is being funded by nearly $65 million in new money from the American Recovery and Reinvestment Act of 2009 (ARRA).
New findings by University of California, Berkeley, scientists including Molecular & Cell Biology Associate Professor Abby Dernburg show that the cell's cytoskeleton, which moves things around in the cell, plays a critical role, essentially reaching into the nucleus to bring chromosome pairs together in preparation for recombination and segregation.
The bulk of the work for which Elizabeth Blackburn, Carol Greider and John Szostak won this year's Nobel Prize in Physiology or Medicine took place at the University of California, Berkeley, when Blackburn was a professor of molecular and cell biology and Greider was her graduate student.
Kathleen Collins, a professor in the Department of Molecular & Cell Biology, has made it her business to understand everything she can about this so-called immortality enzyme. Her discoveries about its regulation, assembly and connections to human disease are leading the way toward methods to regulate its production and perhaps treat disorders such as cancer.
Jocelyn E. Krebs who received her PhD from the Department of Molecular & Cell Biology is now the lead author on the newest edition (10th) of a classic molecular biology textbook, now called Lewin's GENES X.
A new way to select and switch on one cell type in an organism using light has helped answer a long-standing question about the function of one class of enigmatic nerve cells in the spinal cord.
Kathy Lynn Hudson, who received her PhD from the Molecular Biology department at UC Berkeley in 1989 and is the founding director of Johns Hopkins University's Genetics & Public Policy Center, has been recruited as the chief of staff of the new National Institutes of Health Director Francis Collins.
A new study by researchers from the University of California, Berkeley, and Berkeley-based Aduro BioTech provides clues why killed and severely attenuated vaccines don‰Ûªt always work. It also suggests ways to engineer an attenuated vaccine to make it as potent as a live vaccine but as safe as a killed vaccine.